Enter Note Done
Go to previous page in this tab
Session
  • Presentation | Late Breaking Poster Session - Late Breaking Poster Session
  • Late Breaking Poster Session
  • Share Icon
    Bookmark Icon
  • 3061-LB - Combination Treatment of Oral Small Molecule GLP-1 Receptor Agonist Aleniglipron and Small Molecule Amylin Receptor Agonist ACCG-2671 Demonstrated Additional Weight Loss than Monotreatment in Obese NHPs [Board No. 3061]
    • Schedule
    Notes
  • Poster Hall (Halls D-E)
    3061-LB
    Set Timezone

X. Fang: Employee; Current; Structure Therapeutics. J. Zhang: None. N. Hu: Employee; Current; Structure Therapeutics. X. Jiang: None. X. Lin: None. F. Zhang: Stock/Shareholder; Current; Eli Lilly and Company, Novo Nordisk A/S.
Type
Main Session